LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 403.48M | 382.20M | 363.81M | 345.31M | 332.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 403.48M | 382.20M | 363.81M | 345.31M | 332.97M |
| Cost of Revenue | 267.54M | 255.90M | 247.23M | 236.88M | 223.18M |
| Gross Profit | 135.93M | 126.30M | 116.58M | 108.43M | 109.79M |
| SG&A Expenses | 100.24M | 94.74M | 95.69M | 97.38M | 94.43M |
| Depreciation & Amortization | 13.32M | 13.43M | 13.56M | 14.01M | 13.76M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 381.11M | 364.08M | 356.48M | 348.26M | 331.37M |
| Operating Income | 22.37M | 18.12M | 7.33M | -2.95M | 1.60M |
| Income Before Tax | 19.76M | 15.20M | 4.57M | -5.94M | -1.47M |
| Income Tax Expenses | 5.52M | 3.54M | 3.50M | -2.15M | -2.18M |
| Earnings from Continuing Operations | 14.24M | 11.67M | 1.08M | -3.79M | 709.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.24M | 11.67M | 1.08M | -3.79M | 709.00K |
| EBIT | 22.37M | 18.12M | 7.33M | -2.95M | 1.60M |
| EBITDA | 35.69M | 31.55M | 20.89M | 11.06M | 15.36M |
| EPS Basic | 0.04 | 0.03 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.03 | 0.02 | 0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.04 | 0.03 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.03 | 0.02 | 0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 387.26M | 387.00M | 386.96M | 386.73M | 383.27M |
| Average Diluted Shares Outstanding | 395.08M | 396.00M | 388.90M | 386.73M | 390.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |